CLEAR CREEK BIO, INC.

ACTIVE

390 Commonwealth Ave APT 605, 马萨诸塞州米德尔塞克斯县, Massachusetts, United Stateswww.clearcreekbio.comPrivate11–50 employeesEstablished: 2017-01-01

Clinical Trials

0 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2017

Overview

Trial Phase Distribution

Phase

Trials

Phase 2

66.7%

Phase 1

33.3%

Trial Status Distribution

Completed

33.3%

Recruiting

33.3%

Terminated

33.3%

Clinical Trials

Trials sponsored by this organization (6)

Brequinar Combined With Dipyridamole in Patients With Mild to Moderate COVID-19

Phase 2

Terminated

interventional

Feb 202226 participants

Study assessing the safety and anti-coronavirus response of brequinar combined with dipyridamole in patients with mild to moderate SARS-CoV-2 infection

Phase 2

Recruiting

interventional

Dec 2021112 participants

CRISIS2: A Phase 2 Study of the Safety and Antiviral Activity of Brequinar in Non-hospitalized Pts With COVID-19

Phase 2

Completed

interventional

Nov 2020115 participants

Safety and Anti-coronavirus Response of Suppression of Host Nucleotide Synthesis in Patients With COVID-19

Phase 1

Completed

interventional

Aug 202025 participants

A Study of Brequinar in Subjects With Relapsed/Refractory Acute Myeloid Leukemia

Phase 1

Terminated

interventional

Dec 201817 participants

Study assessing the safety and anti-coronavirus response of brequinar combined with dipyridamole in patients with mild to moderate SARS-CoV-2 infectio

Phase 2

Recruiting

interventional

Approvals

No approval data available

News

No news articles found

Back to Organizations